STOCK ALARM
SA
Menu
Set Alert
Demo
Go Pro
Log In
Today
My Portfolio
Find Stocks
The Market
Charts
Research
Advisor
⌘J
PDLI
(PDLI)
PDLI
Overview
Intelligence
Chart
Fundamentals
Key Metrics
Earnings
Growth
Analysts
Financials
Insiders
Institutional
More
Key Metrics
As of
2019
• vs 2018
Annual
Quarterly
Core Metrics
Market Cap
$384.96M
-8.9%
P/E Ratio
-5.47
+10.9%
P/S Ratio
7.03
+225.8%
ROE
-11.87%
-25.8%
ROIC
-9.52%
-231.4%
FCF Yield
-9.07%
-0.9%
Debt/Equity
0.06
-65.5%
Current Ratio
6.87
-30.3%
Interest Coverage
-5.84x
-207.6%
Per Share
Revenue/Share
$0.46
-65.7%
Net Income/Share
$-0.59
-25.6%
Operating CF/Share
$-0.27
-196.7%
Free CF/Share
$-0.29
-12.9%
Cash/Share
$1.63
-39.8%
Book Value/Share
$5.00
-0.2%
Tangible Book/Share
$2.56
+23.5%
Equity/Share
$5.00
-0.2%
Interest Debt/Share
$0.42
-58.9%
Valuation
Market Cap
$384.96M
-8.9%
Enterprise Value
$229.46M
+40.6%
P/E Ratio
-5.47
+10.9%
P/S Ratio
7.03
+225.8%
P/OCF Ratio
-11.87
+62.3%
P/FCF Ratio
-11.03
+0.9%
P/B Ratio
0.65
+12.1%
P/TB Ratio
0.65
+12.1%
EV/Sales
4.19
+402.7%
EV/EBITDA
-4.16
+28.8%
Profitability
Earnings Yield
-18.29%
-12.2%
FCF Yield
-9.07%
-0.9%
ROE
-11.87%
-25.8%
ROIC
-9.52%
-231.4%
Return on Tangible Assets
-16.50%
-28.4%
Capital Allocation
CapEx/OCF
-7.59%
+95.8%
CapEx/Revenue
4.50%
-64.1%
CapEx/Depreciation
0.34
-77.9%
SBC/Revenue
13.00%
+434.9%
Balance Sheet
Debt/Equity
0.06
-65.5%
Debt/Assets
0.05
-62.3%
Net Debt/EBITDA
2.82
-69.6%
Current Ratio
6.87
-30.3%
Interest Coverage
-5.84x
-207.6%
Income Quality
0.46
+136.3%
Efficiency
Days Sales Outstanding
441 days
+179.2%
Days Payables Outstanding
118 days
+19.5%
Days Inventory
271 days
+89.8%
Receivables Turnover
0.83x
-64.2%
Payables Turnover
3.09x
-16.3%
Inventory Turnover
1.35x
-47.3%
Special Valuations
Graham Number
--
Graham Net-Net
$1.18
-26.4%
Explore More
S&P 500 Screener
Filter and sort all 500 stocks
Market Movers
Today's biggest gainers and losers
Market Heatmap
Visual sector performance
Home
Screener
Alerts
Search
More
PDL Biopharma Inc
(PDLI)
$2.47
▼
-0.23 (-8.52%)
Chart
Share
Post on X
PDLI
PDL Biopharma Inc
(PDLI)
NASDAQ
$2.47
▼
-0.23 (-8.52%)
Chart Studio
Share
PDLI